InMed Pharmaceuticals (INM) Shares Outstanding (2019 - 2026)

InMed Pharmaceuticals' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $166410.0 for Q3 2023.

• On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $166410.0 in Q3 2023; TTM through Sep 2023 was $166410.0, a N/A change from a year earlier, with the FY2023 full-year figure at $122423.0, changed N/A from the prior year.
• Shares Outstanding (Entity) rose to $166410.0 in Q3 2023 per INM's latest filing, from $122423.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $166410.0 in Q3 2023 and bottomed at $105.0 in Q2 2020.
• The 5-year median for Shares Outstanding (Entity) is $13271.0 (2019), against an average of $45616.2.
• Biggest YoY gain for Shares Outstanding (Entity) was 15234.29% in 2021; the steepest drop was 15234.29% in 2021.
• Year by year, Shares Outstanding (Entity) stood at $10441.0 in 2019, then tumbled by 98.99% to $105.0 in 2020, then soared by 15234.29% to $16101.0 in 2021, then soared by 77.43% to $28568.0 in 2022, then surged by 482.5% to $166410.0 in 2023.
• Per Business Quant, the three latest INM Shares Outstanding (Entity) figures stand at $166410.0 (Q3 2023), $122423.0 (Q2 2023), and $28568.0 (Q1 2022).